The last exercise period of Brighter TO4 starts today
August 25 to September 8, 2020 is the last exercise period of Brighter TO4 during which holders of these warrants can subscribe for shares. One warrant gives the right to subscribe for one share at the subscription price of SEK 2. The TO4 warrants will after this exercise period become worthless and the holder will no longer have any right to subscribe for the shares.
Holders of TO4 warrants who have their warrants registered in custody at a bank or broker shall contact their bank or broker if they want to exercise the warrants and subscribe for the corresponding shares.
Exercise of the warrants and subscription of shares for the other holders of warrants, those who do not have their warrants registered with a bank or broker, takes place through simultaneous payment and submittal of the registered application form, signed and delivered to the Company’s share agent, Eminova Fondkommission, no later than 16:00 CET on September 8, 2020. The application form is provided by Eminova Fondkommission.
For inquiries please contact Eminova Fondkommission, by phone at 08-684 211 00 or by email at email@example.com.
For further information, please contact:
Ann Zetterberg, CFO
+46 708 37 21 23
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, firstname.lastname@example.org, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.